Trial Profile
A Randomized, Placebo-Controlled, Double-Blind, Prospective Clinical Trial of Botulinum Toxin Type A in Prevention of Hypertrophic Scar Development in Median Sternotomy Wound
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 29 Jan 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hypertrophic scars
- Focus Therapeutic Use
- 23 Jan 2018 Status changed from recruiting to completed.
- 24 Jan 2017 Status changed from not yet recruiting to recruiting.
- 20 Sep 2016 New trial record